\-\ Texto\\:\\ \ \(0\)\
\-\ calcium\\,\\ ionized\\ \\-\\ low\ \(0\)\
\-\ serum\\ phosphorus\\ \\-\\ low\ \(0\)\
\-\ serum\\ alkaline\\ phosphatase\\ \\-\\ elevated\ \(0\)\
\-\ treatment\\:\\ administered\\ gradually\\ over\\ several\\ months\\ or\\ in\\ a\\ single\\ day\\'s\\ dose\\ with\\ 15\\,000\\ mcg\\ \\(600\\,000\\ u\\)\\ of\\ vitamin\\ d\\.\\ if\\ the\\ gradual\\ method\\ is\\ chosen\\,\\ 125\\-250\\ mcg\\ \\(5000\\-10\\,000\\ u\\)\\ is\\ given\\ daily\\ for\\ 2\\-3\\ months\\ until\\ healing\\ is\\ well\\ established\\ and\\ the\\ alkaline\\ phosphatase\\ concentration\\ is\\ approaching\\ the\\ reference\\ range\\.\\ because\\ this\\ method\\ requires\\ daily\\ treatment\\,\\ success\\ depends\\ on\\ compliance\\.\ \(0\)\
\-\ an\\ alternative\\ and\\ recommended\\ therapy\\ is\\ to\\ administer\\ the\\ vitamin\\ d\\ in\\ a\\ single\\ day\\,\\ usually\\ divided\\ into\\ 4\\ or\\ 6\\ oral\\ doses\\.\\ an\\ intramuscular\\ injection\\ also\\ is\\ available\\.\\ vitamin\\ d\\ is\\ well\\ stored\\ in\\ the\\ body\\ and\\ released\\ gradually\\ over\\ many\\ weeks\\.\\ neither\\ calcitriol\\ nor\\ calcidiol\\ with\\ their\\ short\\ half\\-lives\\ are\\ suitable\\.\\ \ \(0\)\
\-\ prevention\\:\\ 10\\ mcg\\ \\(400u\\)\\ po\\ daily\\ vitamin\\ d\\ preparation\\ and\\ an\\ adequate\\ dietary\\ supply\\ of\\ calcium\\ and\\ phosphorus\\ prevent\\ rickets\\.\\ as\\ little\\ as\\ 20\\ min\\/d\\ of\\ ultraviolet\\ light\\ to\\ the\\ face\\ of\\ a\\ light\\-skinned\\ baby\\ is\\ sufficient\\;\\ however\\,\\ significantly\\ longer\\ periods\\ of\\ exposure\\ are\\ necessary\\ for\\ children\\ with\\ melanotic\\ skin\\.\ \(0\)\
\-\ bilateral\\ wrists\\,\\ knees\\:\\ there\\ is\\ loss\\ of\\ the\\ zone\\ of\\ provisional\\ calcification\\ in\\ the\\ metaphyses\\ with\\ slight\\ irregularity\\ and\\ cupping\\ of\\ the\\ metaphyses\\ of\ \(0\)\
\-\ all\\ the\\ bones\\ imaged\\.\\ there\\ is\\ also\\ apparent\\ widening\\ of\\ the\\ physes\\.\\ thin\\ periosteal\\ reaction\\ along\\ the\\ radial\\ aspect\\ of\\ the\\ distal\\ ulna\\,\\ likely\\ healing\\ insufficiency\\ fracture\\.\ \(0\)\
\-\ rickets\ \(46\)\
\-\ failure\\ of\\ osteoid\\ calcification\\ \\(rickets\\)\\ \\(secondary\\ to\\ a\\ disorder\\ in\\ the\\ pathway\\ of\\ either\\ vitamin\\ d\\ or\\ phosphate\\ metabolism\\)\\:\ \(0\)\
\-\ 1\\.\\ familial\\ hypophosphatemia\\ \\(formerly\\ vitamin\\ d\\â\\€\\“resistant\\ rickets\\)\\ \ \(0\)\
\-\ 2\\.\\ vitamin\\ d\\â\\€\\“dependent\\ rickets\\ type\\ i\\ \ \(0\)\
\-\ 3\\.\\ receptor\\ defect\\ rickets\\ \\(formerly\\ vitamin\\ d\\â\\€\\“dependent\\ rickets\\ type\\ ii\\)\\ \ \(0\)\
\-\ 4\\.\\ defective\\ 25\\-hydroxylase\\ \ \(0\)\
\-\ 5\\.\\ fanconi\\ syndrome\\ \\(rta\\ with\\ phosphate\\ wasting\\)\ \(0\)\
\-\ 6\\.\\ osteodystrophy\\ \\(ie\\,\\ renal\\ rickets\\)\\ and\\ hypophosphatasia\ \(0\)\
\-\ male\\ infant\\ with\\ hypocalcemia\\.\\ breast\\-fed\\ without\\ oral\\ supplementation\\.\ \(0\)\
\-\ human\\ milk\\ contains\\ little\\ vitamin\\ d\\,\\ and\\,\\ for\\ babies\\ weighing\\ less\\ than\\ 1500\\ g\\,\\ it\\ also\\ contains\\ too\\ little\\ phosphate\\.\\ special\\ supplementation\\ \\(vitamin\\ d\\,\\ calcium\\,\\ phosphate\\)\\ is\\ important\\ if\\ breast\\ milk\\ is\\ primary\\ dietary\\ source\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ vitamin\\:\\ 0\\.13068386467657758\ \(0\)\
\-\ rickets\\:\\ 0\\.11182402533987225\ \(0\)\
\-\ mcg\\:\\ 0\\.0686923513555831\ \(0\)\
\-\ phosphate\\:\\ 0\\.06667660416798055\ \(0\)\
\-\ d\\:\\ 0\\.06641519271219674\ \(0\)\
\-\ d\\â\\€\\“dependent\\:\\ 0\\.04579490090372207\ \(0\)\
\-\ formerly\\:\\ 0\\.03648705950513477\ \(0\)\
\-\ little\\:\\ 0\\.0361646583434093\ \(0\)\
\-\ u\\:\\ 0\\.034992607180709935\ \(0\)\
\-\ daily\\:\\ 0\\.034449890410083575\ \(0\)\
\-\ milk\\:\\ 0\\.0338334199011556\ \(0\)\
\-\ phosphorus\\:\\ 0\\.03333830208399027\ \(0\)\
\-\ supplementation\\:\\ 0\\.03333830208399027\ \(0\)\
\-\ calcium\\:\\ 0\\.0325775800187288\ \(0\)\
\-\ metaphyses\\:\\ 0\\.03139184260637255\ \(0\)\
\-\ dietary\\:\\ 0\\.029737537509652894\ \(0\)\
\-\ phosphatase\\:\\ 0\\.029073468047263882\ \(0\)\
\-\ alkaline\\:\\ 0\\.028302455033662462\ \(0\)\
\-\ method\\:\\ 0\\.027631225259740353\ \(0\)\
\-\ gradually\\:\\ 0\\.025794134141591894\ \(0\)\
\-\ contains\\:\\ 0\\.023724795750218904\ \(0\)\
\-\ healing\\:\\ 0\\.022902852865985687\ \(0\)\
\-\ 125\\-250\\:\\ 0\\.022897450451861034\ \(0\)\
\-\ 5000\\-10\\,000\\:\\ 0\\.022897450451861034\ \(0\)\
\-\ half\\-lives\\:\\ 0\\.022897450451861034\ \(0\)\
\-\ 400u\\:\\ 0\\.022897450451861034\ \(0\)\
\-\ min\\/d\\:\\ 0\\.022897450451861034\ \(0\)\
\-\ ultraviolet\\:\\ 0\\.022897450451861034\ \(0\)\
\-\ light\\-skinned\\:\\ 0\\.022897450451861034\ \(0\)\
\-\ d\\â\\€\\“resistant\\:\\ 0\\.022897450451861034\ \(0\)\
\-\ 25\\-hydroxylase\\:\\ 0\\.022897450451861034\ \(0\)\
\-\ rta\\:\\ 0\\.022897450451861034\ \(0\)\
\-\ breast\\-fed\\:\\ 0\\.022897450451861034\ \(0\)\
\-\ serum\\:\\ 0\\.021424262554479767\ \(0\)\
\-\ administer\\:\\ 0\\.021097068164692347\ \(0\)\
\-\ stored\\:\\ 0\\.021097068164692347\ \(0\)\
\-\ calcitriol\\:\\ 0\\.021097068164692347\ \(0\)\
\-\ melanotic\\:\\ 0\\.021097068164692347\ \(0\)\
\-\ 15\\,000\\:\\ 0\\.020043912039736073\ \(0\)\
\-\ calcidiol\\:\\ 0\\.020043912039736073\ \(0\)\
\-\ defective\\:\\ 0\\.020043912039736073\ \(0\)\
\-\ fanconi\\:\\ 0\\.020043912039736073\ \(0\)\
\-\ 600\\,000\\:\\ 0\\.019296685877523655\ \(0\)\
\-\ hypocalcemia\\:\\ 0\\.019296685877523655\ \(0\)\
\-\ \\(\\:\\ 0\\.018762642240100276\ \(0\)\
\-\ hypophosphatemia\\:\\ 0\\.018717092237746487\ \(0\)\
\-\ babies\\:\\ 0\\.018717092237746487\ \(0\)\
\-\ oral\\:\\ 0\\.018704325539519544\ \(0\)\
\-\ \\)\\:\\ 0\\.018533446548397534\ \(0\)\
\-\ ionized\\:\\ 0\\.018243529752567385\ \(0\)\
\-\ suitable\\:\\ 0\\.018243529752567385\ \(0\)\
\-\ physes\\:\\ 0\\.018243529752567385\ \(0\)\
\-\ wasting\\:\\ 0\\.018243529752567385\ \(0\)\
\-\ 1500\\:\\ 0\\.018243529752567385\ \(0\)\
\-\ single\\:\\ 0\\.017993040470080164\ \(0\)\
\-\ is\\:\\ 0\\.017525946339264176\ \(0\)\
\-\ approaching\\:\\ 0\\.017496303590354968\ \(0\)\
\-\ compliance\\:\\ 0\\.017496303590354968\ \(0\)\
\-\ provisional\\:\\ 0\\.01719037362761111\ \(0\)\
\-\ hypophosphatasia\\:\\ 0\\.0169167099505778\ \(0\)\
\-\ preparation\\:\\ 0\\.016669151041995137\ \(0\)\
\-\ pathway\\:\\ 0\\.016443147465398694\ \(0\)\
\-\ receptor\\:\\ 0\\.016443147465398694\ \(0\)\
\-\ chosen\\:\\ 0\\.016235244328584315\ \(0\)\
\-\ calcification\\:\\ 0\\.016113172043933137\ \(0\)\
\-\ human\\:\\ 0\\.016042756089223998\ \(0\)\
\-\ doses\\:\\ 0\\.01586355382562153\ \(0\)\
\-\ intramuscular\\:\\ 0\\.01586355382562153\ \(0\)\
\-\ prevention\\:\\ 0\\.01586355382562153\ \(0\)\
\-\ cupping\\:\\ 0\\.01586355382562153\ \(0\)\
\-\ periods\\:\\ 0\\.015695921303186276\ \(0\)\
\-\ weighing\\:\\ 0\\.015389991340442425\ \(0\)\
\-\ concentration\\:\\ 0\\.015249556999480671\ \(0\)\
\-\ alternative\\:\\ 0\\.01511632766340911\ \(0\)\
\-\ type\\:\\ 0\\.014964281705698235\ \(0\)\
\-\ neither\\:\\ 0\\.014868768754826447\ \(0\)\
\-\ depends\\:\\ 0\\.01475330963126584\ \(0\)\
\-\ osteodystrophy\\:\\ 0\\.014642765178230006\ \(0\)\
\-\ wrists\\:\\ 0\\.014434862041415626\ \(0\)\
\-\ metabolism\\:\\ 0\\.014434862041415626\ \(0\)\
\-\ ie\\:\\ 0\\.014434862041415626\ \(0\)\
\-\ special\\:\\ 0\\.014434862041415626\ \(0\)\
\-\ \\-\\:\\ 0\\.01427320876915608\ \(0\)\
\-\ gradual\\:\\ 0\\.014242373802055308\ \(0\)\
\-\ released\\:\\ 0\\.014242373802055308\ \(0\)\
\-\ day\\:\\ 0\\.014093297814820414\ \(0\)\
\-\ divided\\:\\ 0\\.013978003167484031\ \(0\)\
\-\ sufficient\\:\\ 0\\.013815612629870177\ \(0\)\
\-\ osteoid\\:\\ 0\\.013815612629870177\ \(0\)\
\-\ imaged\\:\\ 0\\.013662780162278142\ \(0\)\
\-\ established\\:\\ 0\\.013589609053273737\ \(0\)\
\-\ familial\\:\\ 0\\.013589609053273737\ \(0\)\
\-\ success\\:\\ 0\\.01351844288655136\ \(0\)\
\-\ ulna\\:\\ 0\\.013381705916459355\ \(0\)\
\-\ d\\.\\:\\ 0\\.013189217677099038\ \(0\)\
\-\ g\\:\\ 0\\.013128099502007625\ \(0\)\
\-\ also\\:\\ 0\\.013126905924702477\ \(0\)\
\-\ knees\\:\\ 0\\.012897067070795947\ \(0\)\
\-\ administered\\:\\ 0\\.01278882630092434\ \(0\)\
\-\ po\\:\\ 0\\.01268491634088876\ \(0\)\
\-\ longer\\:\\ 0\\.012536452928317465\ \(0\)\
\-\ too\\:\\ 0\\.01244199151488662\ \(0\)\
\-\ supply\\:\\ 0\\.012350845229662543\ \(0\)\
\-\ low\\:\\ 0\\.012343730144760517\ \(0\)\
\-\ months\\:\\ 0\\.012124370362026323\ \(0\)\
\-\ if\\:\\ 0\\.01204542043522408\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.01197617092097541\ \(0\)\
\-\ reference\\:\\ 0\\.011937690178676342\ \(0\)\
\-\ adequate\\:\\ 0\\.011899771219140879\ \(0\)\
\-\ nor\\:\\ 0\\.011862397875109452\ \(0\)\
\-\ irregularity\\:\\ 0\\.011862397875109452\ \(0\)\
\-\ requires\\:\\ 0\\.011789226766105047\ \(0\)\
\-\ zone\\:\\ 0\\.011789226766105047\ \(0\)\
\-\ insufficiency\\:\\ 0\\.011789226766105047\ \(0\)\
\-\ \\:\\:\\ 0\\.011743114971331585\ \(0\)\
\-\ source\\:\\ 0\\.01171806059938267\ \(0\)\
\-\ dose\\:\\ 0\\.01161483896652679\ \(0\)\
\-\ exposure\\:\\ 0\\.011548235250647992\ \(0\)\
\-\ significantly\\:\\ 0\\.011358096538899173\ \(0\)\
\-\ over\\:\\ 0\\.011302039429298506\ \(0\)\
\-\ widening\\:\\ 0\\.01118093225311597\ \(0\)\
\-\ prevent\\:\\ 0\\.01101508427393017\ \(0\)\
\-\ face\\:\\ 0\\.01088453405372007\ \(0\)\
\-\ baby\\:\\ 0\\.010809241750153183\ \(0\)\
\-\ 6\\.\\:\\ 0\\.010784621635985536\ \(0\)\
\-\ periosteal\\:\\ 0\\.010528167504334395\ \(0\)\
\-\ infant\\:\\ 0\\.01050606181688528\ \(0\)\
\-\ short\\:\\ 0\\.010462406964115462\ \(0\)\
\-\ slight\\:\\ 0\\.010440851632129239\ \(0\)\
\-\ injection\\:\\ 0\\.010356375809517395\ \(0\)\
\-\ light\\:\\ 0\\.010356375809517395\ \(0\)\
\-\ radial\\:\\ 0\\.010175788633806719\ \(0\)\
\-\ reaction\\:\\ 0\\.010080635041131965\ \(0\)\
\-\ well\\:\\ 0\\.010041978976460525\ \(0\)\
\-\ disorder\\:\\ 0\\.009970869302716685\ \(0\)\
\-\ important\\:\\ 0\\.009970869302716685\ \(0\)\
\-\ necessary\\:\\ 0\\.009831377928763799\ \(0\)\
\-\ apparent\\:\\ 0\\.009814456679358102\ \(0\)\
\-\ until\\:\\ 0\\.009747852963479303\ \(0\)\
\-\ their\\:\\ 0\\.009715180801903043\ \(0\)\
\-\ either\\:\\ 0\\.009666930449765548\ \(0\)\
\-\ children\\:\\ 0\\.00958845310276166\ \(0\)\
\-\ ii\\:\\ 0\\.009573038205307596\ \(0\)\
\-\ 5\\.\\:\\ 0\\.009573038205307596\ \(0\)\
\-\ bones\\:\\ 0\\.009366317587337863\ \(0\)\
\-\ an\\:\\ 0\\.009207778163257635\ \(0\)\
\-\ recommended\\:\\ 0\\.00920134770234481\ \(0\)\
\-\ i\\:\\ 0\\.009174843364229896\ \(0\)\
\-\ \\,\\:\\ 0\\.009140859355129184\ \(0\)\
\-\ many\\:\\ 0\\.009122632508850448\ \(0\)\
\-\ thin\\:\\ 0\\.009122632508850448\ \(0\)\
\-\ treatment\\:\\ 0\\.008985023166757854\ \(0\)\
\-\ range\\:\\ 0\\.008935688353980085\ \(0\)\
\-\ 4\\.\\:\\ 0\\.008738909014028046\ \(0\)\
\-\ failure\\:\\ 0\\.00869469683852303\ \(0\)\
\-\ skin\\:\\ 0\\.008525010221399943\ \(0\)\
\-\ defect\\:\\ 0\\.008308434613766043\ \(0\)\
\-\ breast\\:\\ 0\\.008188462191767668\ \(0\)\
\-\ 20\\:\\ 0\\.007980559054953288\ \(0\)\
\-\ or\\:\\ 0\\.0078040733685483706\ \(0\)\
\-\ because\\:\\ 0\\.007764982640483241\ \(0\)\
\-\ given\\:\\ 0\\.0076088685519905\ \(0\)\
\-\ 3\\.\\:\\ 0\\.0075944784730927984\ \(0\)\
\-\ elevated\\:\\ 0\\.007530691847685878\ \(0\)\
\-\ less\\:\\ 0\\.007516727283955019\ \(0\)\
\-\ 10\\:\\ 0\\.007482140852849118\ \(0\)\
\-\ available\\:\\ 0\\.007461607919064408\ \(0\)\
\-\ along\\:\\ 0\\.0073352048749571845\ \(0\)\
\-\ body\\:\\ 0\\.007208477175815803\ \(0\)\
\-\ several\\:\\ 0\\.007135306066811396\ \(0\)\
\-\ 2\\.\\:\\ 0\\.007058296472208463\ \(0\)\
\-\ aspect\\:\\ 0\\.006972186842813915\ \(0\)\
\-\ 1\\.\\:\\ 0\\.006932958873500262\ \(0\)\
\-\ usually\\:\\ 0\\.006740073386666907\ \(0\)\
\-\ as\\:\\ 0\\.006714688342307157\ \(0\)\
\-\ renal\\:\\ 0\\.00666876766093005\ \(0\)\
\-\ 6\\:\\ 0\\.006628883536038635\ \(0\)\
\-\ there\\:\\ 0\\.006606314579038902\ \(0\)\
\-\ primary\\:\\ 0\\.006575024059469341\ \(0\)\
\-\ loss\\:\\ 0\\.006442764084333609\ \(0\)\
\-\ syndrome\\:\\ 0\\.006347809290219848\ \(0\)\
\-\ weeks\\:\\ 0\\.006299422745197788\ \(0\)\
\-\ all\\:\\ 0\\.006277723349172184\ \(0\)\
\-\ likely\\:\\ 0\\.006260493418014692\ \(0\)\
\-\ secondary\\:\\ 0\\.006205272640282617\ \(0\)\
\-\ 4\\:\\ 0\\.006184342610854663\ \(0\)\
\-\ however\\:\\ 0\\.006180176767784599\ \(0\)\
\-\ are\\:\\ 0\\.006051292844309619\ \(0\)\
\-\ distal\\:\\ 0\\.0060344898414182516\ \(0\)\
\-\ therapy\\:\\ 0\\.005934131938287307\ \(0\)\
\-\ fracture\\:\\ 0\\.005852141117591633\ \(0\)\
\-\ than\\:\\ 0\\.005815711311476036\ \(0\)\
\-\ for\\:\\ 0\\.005681362197215962\ \(0\)\
\-\ in\\:\\ 0\\.0054726913005227916\ \(0\)\
\-\ bilateral\\:\\ 0\\.005386539556660894\ \(0\)\
\-\ into\\:\\ 0\\.005281367189505732\ \(0\)\
\-\ \\;\\:\\ 0\\.005260834255721022\ \(0\)\
\-\ without\\:\\ 0\\.00522600822430691\ \(0\)\
\-\ the\\:\\ 0\\.005027246716495484\ \(0\)\
\-\ it\\:\\ 0\\.004989216583202641\ \(0\)\
\-\ \\'s\\:\\ 0\\.0048936275801741425\ \(0\)\
\-\ a\\:\\ 0\\.004120517421491961\ \(0\)\
\-\ male\\:\\ 0\\.0040135208776298\ \(0\)\
\-\ of\\:\\ 0\\.003933894572399609\ \(0\)\
\-\ and\\:\\ 0\\.003740446872357786\ \(0\)\
\-\ to\\:\\ 0\\.00332780344241288\ \(0\)\
\-\ this\\:\\ 0\\.0024964602943224235\ \(0\)\
\-\ on\\:\\ 0\\.0018802363957543587\ \(0\)\
\-\ with\\:\\ 0\\.0018234417052969828\ \(0\)\
\-\ \\.\\:\\ 0\\.001383098808987517\ \(0\)\
